Application
The anti-UBC9 Mab (Cat. #AM1261b) is used in Western blot to detect UBC9 in HL60 cell lysate.| Product Name | UBC9 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | UBE2I; UBC9; UBCE9; SUMO-conjugating enzyme UBC9; SUMO-protein ligase; Ubiquitin carrier protein 9; Ubiquitin carrier protein I; Ubiquitin-conjugating enzyme E2 I; Ubiquitin-protein ligase I; p18 |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Clone Number | 67AT72.243.80 |
| Host Species | Mouse |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | UBC9 UBCE9 |
|---|---|
| Alternative Names | UBE2I UBC9 UBCE9 SUMO-conjugating enzyme UBC9 SUMO-protein ligase Ubiquitin carrier protein 9 Ubiquitin carrier protein I Ubiquitin-conjugating enzyme E2 I Ubiquitin-protein ligase I p18 |
| Molecular Weight(MW) | 18007 Da |
| Function | Accepts the ubiquitin-like proteins SUMO1, SUMO2, SUMO3 and SUMO4 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2 or CBX4. Can catalyze the formation of poly- SUMO chains. Necessary for sumoylation of FOXL2 and KAT5 Essential for nuclear architecture and chromosome segregation |
| Tissue Specificity | Expressed in heart, skeletal muscle, pancreas, kidney, liver, lung, placenta and brain. Also expressed in testis and thymus |
| Cellular Localization | Nucleus. Cytoplasm. Note=Mainly nuclear. In spermatocytes, localizes in synaptonemal complexes. Recruited by BCL11A into the nuclear body (By similarity) |
| Entrez Gene | 7329 |
|---|
Application
The anti-UBC9 Mab (Cat. #AM1261b) is used in Western blot to detect UBC9 in HL60 cell lysate.| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. |
